Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 14, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Determining EBV load: current best practice and future requirements.

Stephanie Ruf¹, Hans-Joachim Wagner

¹Department of Pediatric Hematology and Oncology, University Hospital of Giessen, Germany.

Expert Review of Clinical Immunology

|February 9, 2013

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Generation of a recipient line for Rubisco engineering by multiplex genome editing in tobacco.

The Plant journal : for cell and molecular biology·2026

Same author

Proton channel inactivation results in loss of chloroplast NDH complex activity.

Plant physiology·2026

Same author

Plastid Engineering for Photosynthesis-Driven Synthesis of Hyaluronic Acid in Tobacco.

Plant biotechnology journal·2025

Same author

A Set of Intein-Split Selectable Marker Genes for Efficient Co-Transformation.

Plant biotechnology journal·2025

Same author

Development of chloroplast transformation for five species in the genus Nicotiana.

The Plant journal : for cell and molecular biology·2025

Same author

Assembly-dependent translational feedback regulation of photosynthetic proteins in land plants.

Nature plants·2025

Same journal

Dendritic cell subsets in alopecia areata: focus on plasmacytoid dendritic cells and Langerhans cells in immune imbalance and therapeutic implications.

Expert review of clinical immunology·2026

Same journal

The role of immunosenescence and chronic medical conditions on the immune response to respiratory syncytial virus in older individuals.

Expert review of clinical immunology·2026

Same journal

Flow cytometry-based basophil and mast cell activation tests for IgE-mediated food and drug allergy: have we crossed the Rubicon?

Expert review of clinical immunology·2026

Same journal

An update on the pharmacotherapy of ANCA-associated vasculitis.

Expert review of clinical immunology·2026

Same journal

Targeting the cytokine storm: new therapies in the treatment of pediatric hemophagocytic lymphohistiocytosis.

Expert review of clinical immunology·2026

Same journal

Why is the antigen uptake receptor DEC205 (CD205) of interest?

Expert review of clinical immunology·2026

See all related articles

Epstein-Barr virus (EBV) DNA load measurement aids in diagnosing, predicting outcomes, and monitoring EBV-associated cancers. This review examines optimal methods and specimens for EBV detection in various malignancies.

Area of Science:

Virology
Oncology
Molecular Diagnostics

Background:

Epstein-Barr virus (EBV), a gammaherpesvirus, causes infectious mononucleosis and is linked to numerous lymphoid and epithelial cancers.
Quantitative EBV-DNA load measurement via PCR is valuable for diagnosing EBV-associated diseases, predicting patient outcomes, and monitoring immunosuppressed individuals.
Despite an international WHO standard for EBV quantification since 2011, optimal detection methods, amplified genome regions, and specimen types require further clarification, especially for different malignancies.

Purpose of the Study:

To review current methods for measuring Epstein-Barr virus (EBV) DNA load.
To identify the most suitable specimens for EBV detection across various EBV-associated malignancies.
To discuss future directions and opportunities in EBV load quantification.

More Related Videos

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Related Experiment Videos

Last Updated: May 14, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Main Methods:

Literature review of studies on EBV load measurement techniques.
Analysis of specimen suitability for EBV detection in different cancer types.
Discussion of PCR-based quantification methods and genomic targets.

Main Results:

EBV-DNA load measurement is a recognized tool for diagnosis, prognosis, and patient monitoring.
Optimal specimen types and amplified EBV genome regions may differ depending on the specific malignancy.
Existing quantification methods require refinement for broader clinical application.

Conclusions:

Accurate EBV load measurement is crucial for managing EBV-associated diseases.
Standardization of specimen selection and amplification targets is needed for improved diagnostic and prognostic accuracy.
Further research is required to optimize EBV detection methods for diverse clinical settings.